rolipram has been researched along with African Sleeping Sickness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bland, ND | 1 |
| Wang, C | 1 |
| Tallman, C | 1 |
| Gustafson, AE | 1 |
| Wang, Z | 1 |
| Ashton, TD | 1 |
| Ochiana, SO | 1 |
| McAllister, G | 1 |
| Cotter, K | 1 |
| Fang, AP | 1 |
| Gechijian, L | 1 |
| Garceau, N | 1 |
| Gangurde, R | 1 |
| Ortenberg, R | 1 |
| Ondrechen, MJ | 1 |
| Campbell, RK | 1 |
| Pollastri, MP | 1 |
1 other study available for rolipram and African Sleeping Sickness
| Article | Year |
|---|---|
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Benzamides; Catalytic Domain; Humans; Models, Molecular; Molecu | 2011 |